Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E36.04 EPS (ttm)1.07 Insider Own0.50% Shs Outstand2.53B Perf Week-2.04%
Market Cap97.43B Forward P/E20.42 EPS next Y1.88 Insider Trans0.00% Shs Float2.53B Perf Month3.44%
Income2.71B PEG2.95 EPS next Q0.46 Inst Own16.60% Short Float0.39% Perf Quarter5.34%
Sales22.34B P/S4.36 EPS this Y-13.40% Inst Trans-0.16% Short Ratio2.60 Perf Half Y11.64%
Book/sh4.99 P/B7.71 EPS next Y12.08% ROA4.20% Target Price39.89 Perf Year32.31%
Cash/sh1.49 P/C25.80 EPS next 5Y12.20% ROE19.70% 52W Range28.78 - 39.76 Perf YTD10.81%
Dividend1.40 P/FCF- EPS past 5Y-13.50% ROI13.30% 52W High-4.64% Beta0.61
Dividend %3.64% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin80.00% 52W Low31.75% ATR0.55
Employees61100 Current Ratio0.70 Sales Q/Q2.10% Oper. Margin14.70% RSI (14)47.97 Volatility0.96% 1.08%
OptionableYes Debt/Eq1.56 EPS Q/Q-26.60% Profit Margin12.00% Rel Volume1.84 Prev Close38.45
ShortableYes LT Debt/Eq1.22 EarningsJul 26 BMO Payout128.10% Avg Volume3.80M Price37.92
Recom1.80 SMA20-1.28% SMA502.85% SMA2007.55% Volume4,992,209 Change-1.38%
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Aug-15-18 04:20AM  [$$] European Corporate Roundup for Wednesday The Wall Street Journal
Aug-13-18 02:52PM  Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech Benzinga
07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
Aug-08-18 03:36AM  AstraZeneca settles Texas drug lawsuits for $110 mln Reuters
Aug-07-18 04:44PM  AstraZeneca to Pay $110 Million to Settle Texas Drug Suits Bloomberg
10:24AM  Ironwood (IRWD) Q2 Earnings & Revenues Miss, Shares Down Zacks
Aug-03-18 04:09PM  Tesaro CEO Says Its Drug 'Will Get There' Analysts Strongly Disagree Investor's Business Daily
Aug-02-18 07:01PM  To Get the Latest Drugs, Head to China Bloomberg
Aug-01-18 05:24PM  The opioid drug that addicts don't like could be approved next spring American City Business Journals
Jul-30-18 09:49AM  Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT Zacks
03:18AM  Edited Transcript of AZN.L earnings conference call or presentation 26-Jul-18 11:30am GMT Thomson Reuters StreetEvents
Jul-27-18 11:43AM  Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod Zacks
08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga
08:33AM  AstraZeneca's key lung cancer drug wins European panel thumbs-up Reuters
08:29AM  AstraZeneca's key lung cancer drug wins European panel thumbs-up Reuters
02:45AM  Pharma Favorites: 7 Healthy Picks in the Drug Sector Investopedia
Jul-26-18 11:08AM  AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up Zacks
10:37AM  New drugs shine as AstraZeneca treads path back to growth Reuters
07:46AM  AstraZeneca Can't Boost a Cancer Drug Stockpile for Brexit Bloomberg
07:46AM  Astra Stockpiles for Brexit, But Breast Cancer Drug Left Out Bloomberg
07:15AM  Wired News - AstraZeneca Divests European Commercial Rights to Atacand and Atacand Plus to Cheplapharm ACCESSWIRE
05:10AM  AstraZeneca joins U.S. drug price freeze for rest of 2018 Reuters
05:03AM  Astrazeneca: 2Q Earnings Snapshot Associated Press
03:23AM  New drugs shine as AstraZeneca battles through generic losses Reuters
03:22AM  AstraZeneca says 2nd-quarter earnings dropped 27 percent Associated Press
03:05AM  [$$] New drugs boost AstraZeneca sales but patent expiries still weigh Financial Times
02:21AM  AstraZenecas New Medicines Buoy Second-Quarter Results Bloomberg
02:17AM  New drugs help as AstraZeneca battles through generic losses Reuters
Jul-25-18 02:45PM  A Preview Of AstraZeneca's Q2 Earnings Benzinga
08:41AM  Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile Benzinga
Jul-24-18 12:00PM  AstraZeneca Sells Atacand's European Rights to Cheplapharm Zacks
Jul-23-18 08:00AM  Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers GlobeNewswire
Jul-20-18 07:40AM  EU drug regulators step up work to prepare for 'no deal' Brexit Reuters
Jul-18-18 04:36AM  AstraZeneca to stockpile drugs as Brexit 'safety net' Reuters
Jul-13-18 08:18AM  Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial MarketWatch
08:00AM  Today's Research Reports on Trending Tickers: Johnson & Johnson and AstraZeneca ACCESSWIRE
Jul-11-18 04:47AM  Moody's: European pharma sector earnings poised to rise into 2019 as new drugs come to market Moody's
Jul-10-18 12:23PM  Highmark, pharmaceutical company reach deal on diabetes drug American City Business Journals
09:15AM  Biogen Is the Right Alzheimers Stock At the Wrong Time InvestorPlace
Jul-06-18 08:07PM  [$$] Difficult Conversation: When the Harasser Is a Client The Wall Street Journal
09:16AM  Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs Zacks
06:47AM  Hitting cancer early: AstraZeneca's bid to outmaneuver rivals Reuters
02:23AM  Hitting cancer early: AstraZeneca's bid to outmanoeuvre rivals Reuters
Jul-03-18 10:13AM  AstraZeneca's Two New Cancer Drugs Get Approval in Japan Zacks
Jul-02-18 02:15PM  Tesla shares soar after reaching Model 3 production goal, Facebook shares flat and AstraZeneca shares are down Yahoo Finance
10:56AM  Tesla, Facebook and AstraZeneca are the Yahoo Finance charts of the day. Yahoo Finance Video
10:43AM  AstraZeneca wins speedy approvals for cancer drugs in Japan Reuters
Jun-29-18 07:00AM  Blog Exposure AstraZenecas LYNPARZA(R) Reports Encouraging Results from Phase-III 1st-Line SOLO-1 Trial for Advanced Ovarian Cancer ACCESSWIRE
Jun-27-18 07:00AM  LYNPARZA® (olaparib) Significantly Delays Disease Progression in Phase III 1st-Line SOLO-1 Trial for Ovarian Cancer Business Wire
05:14AM  AstraZeneca, Merck eye $1 billion boost from cancer drug success Reuters
05:04AM  AstraZeneca, Merck eye $1 bln boost from cancer drug success Reuters
03:19AM  AstraZeneca, Merck eye wider cancer drug use after study success Reuters
Jun-26-18 08:59AM  Pfizer's Breast Cancer Drug Misses Overall Survival in Study Zacks
Jun-25-18 08:00AM  FARXIGA in Combination with ONGLYZA Demonstrates Similar Glycemic Control with Additional Benefits Vs. Insulin Glargine in Patients with Type 2 Diabetes Business Wire
Jun-24-18 06:32AM  Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines Motley Fool
Jun-21-18 07:28AM  Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug Makers Equities ACCESSWIRE
Jun-19-18 07:00AM  AstraZeneca to Share Latest Data from an Industry-Leading Portfolio That Aims to Advance Clinical Understanding of Diabetes and CV Risk Management at ADA 2018 Business Wire
Jun-15-18 09:27AM  Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals Zacks
Jun-14-18 12:05PM  3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry InvestorPlace
Jun-12-18 10:56PM  [$$] Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimers Drug Trials The Wall Street Journal
07:17PM  [$$] Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer's Drug Trials The Wall Street Journal
04:47PM  Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test TheStreet.com
04:17PM  AstraZeneca, Lilly Join Others On Failed Alzheimer's Drug Heap Investor's Business Daily
10:24AM  Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate Zacks
09:25AM  Alzheimer's Research Stumbles Again: What's the Road Ahead? Zacks
08:35AM  Lilly-AstraZeneca latest to abandon Alzheimer's drug trials Reuters
02:49AM  Another Alzheimer's Drug Fails as Lilly, Astra Halt Tests Bloomberg
12:40AM  [$$] AstraZeneca and Eli Lilly scrap Alzheimers drug trial Financial Times
Jun-11-18 10:57AM  AstraZeneca's Tagrisso Wins EU Nod for First-Line Lung Cancer Zacks
Jun-08-18 07:45AM  New Research: Key Drivers of Growth for Ingersoll-Rand PLC, McEwen Mining, Sociedad Quimica y Minera S.A., AstraZeneca, Worldpay, and Silver Wheaton Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-06-18 07:45PM  Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets PR Newswire
Jun-04-18 06:21PM  LYNPARZA® (olaparib) in Combination With Abiraterone Delayed Disease Progression in Metastatic Castration-Resistant Prostate Cancer Business Wire
11:27AM  AstraZeneca CEO on immunotherapy, drug prices CNBC Videos
10:38AM  Biogen Inc Stock Got an Upgrade, but Should You Listen? InvestorPlace
09:39AM  3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry Zacks
Jun-03-18 07:39PM  PRESS DIGEST- British Business - June 4 Reuters
10:56AM  Merck Wins Again Forbes
Jun-02-18 04:02PM  Moxetumomab Pasudotox Pivotal Data in Patients with Previously-Treated Hairy Cell Leukemia Presented at the 2018 ASCO Meeting Business Wire
Jun-01-18 11:22AM  How Does AstraZeneca PLC (LON:AZN) Fare As A Dividend Stock? Simply Wall St.
May-30-18 10:37AM  Clovis' Rubraca Gets Approval in Europe for Ovarian Cancer Zacks
10:13AM  AstraZeneca (AZN) Stock on Growth Path This Year: Here's Why Zacks
02:49AM  AstraZeneca drug Fasenra fails to achieve main goal in COPD trial Reuters
May-28-18 09:31AM  AstraZeneca's Imfinzi Improves Survival in Lung Cancer Study Zacks
May-25-18 07:00AM  IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer Business Wire
06:14AM  [$$] Stocks to watch: Kingfisher, AstraZeneca, Imperial Brands, Roche Financial Times
03:29AM  AstraZeneca cancer drug hits second goal by extending survival Reuters
May-24-18 08:00AM  AstraZeneca Heads to 2018 ASCO Annual Meeting with Its Diversified Oncology Portfolio and Next-Generation Pipeline Business Wire
May-23-18 05:56PM  Why Big Pharma is finally discovering the Bay Area American City Business Journals
May-22-18 06:03AM  Edited Transcript of AZN.L earnings conference call or presentation 18-May-18 11:00am GMT Thomson Reuters StreetEvents
May-21-18 02:57PM  Stocks Move On Trade Talks As Dow Finds An Unlikely Top Performer In GE Investor's Business Daily
02:45PM  AstraZeneca Gets FDA Nod for Hyperkalaemia Drug Investopedia
12:13PM  U.K. stocks log record close as U.S.-China ease trade-war tensions MarketWatch
11:09AM  AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia Zacks
06:40AM  AstraZeneca potassium drug finally approved, threatening Vifor Reuters
May-18-18 05:51PM  LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia Business Wire
04:22PM  AstraZeneca Blockbuster Is Flailing Will Cancer Drugs Fill The Hole? Investor's Business Daily
03:37PM  Trump talks to Postmaster General about Amazon, plus a retail wrap-up and royal wedding preview Yahoo Finance
02:35PM  Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug Zacks
01:42PM  Astrazeneca PLC (AZN) Q1 2018 Earnings Conference Call Transcript Motley Fool
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.